The reduced BAX/Bcl‐2 ratio in SuHx cells also appears to be driven primarily by increased Bcl‐2 expression, a finding consistent with various tumor cells, where Bcl‐2 expression is enhanced, leading to apoptosis resistance (Kaloni et al., 2023). The gene discussed is BAX; the disease is neoplasm.